TTD Drug ID: DCL000393

Drug Information
Name	GSK835726
Company	GSK
Indication	Allergic rhinitis			Suspended in Phase II in GSK 2009 Report
ClinicalTrials.gov	NCT00851344;
Target	Histamine H1 receptor			Antagonist	[1]
	Histamine H1 receptor			Multitarget	[1]
	Histamine H3 receptor			Antagonist	[1]
	Histamine H3 receptor			Multitarget	[1]
Ref 1	GSK. Product Development Pipeline. February 2009. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.